SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950103-24-004017
Filing Date
2024-03-19
Accepted
2024-03-19 16:17:23
Documents
15
Period of Report
2024-03-19
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K dp208564_8k.htm   iXBRL 8-K 23121
2 EXHIBIT 99.1 dp208564_ex9901.htm EX-99.1 81254
6 GRAPHIC image_001.jpg GRAPHIC 1803
  Complete submission text file 0000950103-24-004017.txt   291389

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE pgen-20240319.xsd EX-101.SCH 3000
4 XBRL LABEL FILE pgen-20240319_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE pgen-20240319_pre.xml EX-101.PRE 22349
18 EXTRACTED XBRL INSTANCE DOCUMENT dp208564_8k_htm.xml XML 3485
Mailing Address 20374 SENECA MEADOWS PARKWAY GERMANTOWN MD 20876
Business Address 20374 SENECA MEADOWS PARKWAY GERMANTOWN MD 20876 301-556-9900
PRECIGEN, INC. (Filer) CIK: 0001356090 (see all company filings)

IRS No.: 000000000 | State of Incorp.: VA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36042 | Film No.: 24763475
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)